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ORIGINAL ARTICLE
Characterization of GH2 and GH42 
β-galactosidases derived from bifidobacterial 
infant isolates
Valentina Ambrogi1,2, Francesca Bottacini1 , Joyce O’Sullivan1, Mary O’Connell Motherway1, Cao Linqiu3, 
Barry Schoemaker3, Margriet Schoterman3 and Douwe van Sinderen1,2*
Abstract 
Bifidobacteria are among the first and most abundant bacterial colonizers of the gastrointestinal tract of (breast-
fed) healthy infants. Their success of colonising the infant gut is believed to be, at least partly, due to their ability 
to metabolize available carbon sources by means of secreted or intracellular glycosyl hydrolases (GHs). Among 
these, β-galactosidases are particularly relevant as they allow bifidobacteria to grow on β-galactosyl-linked saccha-
ridic substrates, which are present in copious amounts in the milk-based diet of their infant host (e.g. lactose and 
human milk oligosaccharides). In the present study we employed an in silico analysis to identify GH family 2 and 42 
β-galactosidases encoded by typical infant-associated bifidobacteria. Comparative genome analysis followed by char-
acterisation of selected β-galactosidases revealed how these GH2 and GH42 members are distributed among these 
infant-associated bifidobacteria, while their hydrolytic activity towards growth substrates commonly available in the 
infant gut were also assessed.
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Introduction
Bifidobacteria are common members of the human gut 
microbiota, and are especially abundant in the gastroin-
testinal tract (GIT) of healthy, breast-fed infants (Milani 
et  al. 2017). The presence of bifidobacteria in the gut is 
believed to provide a number of health benefits for the 
human host, although the mechanisms by which such 
benefits are delivered are currently not fully understood 
(Arboleya et  al. 2016; Milani et  al. 2017). Bifidobacteria 
are saccharolytic microorganisms and their ability to uti-
lize complex dietary glycans or host-derived mucins is an 
important property to assist in their establishment and 
persistence into the GIT (Koropatkin et al. 2012; Milani 
et al. 2015; Riviere et al. 2016). The saccharolytic metab-
olism of bifidobacteria is facilitated by a large array of 
carbohydrate degrading enzymes, in particular glycosyl 
hydrolases (GHs), which provide the capacity to directly 
or indirectly (through syntropy) utilize a range of glycan 
substrates available in the gut (Milani et  al. 2015; Tur-
roni et al. 2018a). Bifidobacteria commonly represent the 
dominant component of the gut microbiota of healthy, 
breast-fed infants (Roger et al. 2010), a phenomenon that 
is believed to be due in part by their ability to metabo-
lize human milk oligosaccharides (HMOs), which contain 
one or more β-linked galactose moieties (Fuhrer et  al. 
2010). Among the glycosyl hydrolases encoded by bifido-
bacteria (Milani et  al. 2015) β-galactosidases (which are 
members of GH families 2 and 42) (van den Broek et al. 
2008) have been described to participate to the utiliza-
tion of (human) milk and milk-based substrates (i.e. lac-
tose, HMOs as well as GOS) in Bifidobacterium bifidum, 
Bifidobacterium longum subsp. infantis and Bifidobacte-
rium breve (Garrido et al. 2013; Goulas et al. 2007; James 
et al. 2016; Miwa et al. 2010; Moller et al. 2001; O’Connell 
Motherway et al. 2013; Yoshida et al. 2012). In addition, 
β-galactosidases in B. bifidum can also participate to the 
degradation of mucin (Turroni et  al. 2010), while in B. 
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breve such enzymes are involved in the degradation of 
the plant polymer galactan (O’Connell Motherway et al. 
2011).
Human milk glycans can be quite diverse and they 
are composed of 13 core structures generated through 
the elongation of lactose at the reducing end with one 
or more β1,3-linked lacto-N-biose (type-I chain) and/or 
β1,3/6-linked N-acetyllactosamine units (type-II chain) 
(Urashima et  al. 2012). These core structures (including 
lactose itself ) can in turn be substituted at terminal posi-
tions by fucose connected via α1,2/3/4 links, and/or sialic 
acid residues attached by α2,3/6 links (Smilowitz et  al. 
2014). Notably, HMOs are especially rich in type-I chains 
and constitute a characteristic feature of human milk 
(Urashima et al. 2012).
Some of the glycosidic linkages and monosaccharides 
found in HMOs are also present in mucins found in the 
intestine, for example the presence of β-linked galactose 
and N-acetyl-glucosamine, as well as fucose and sialic 
acid residues which are substituted to mucin via α1,2/3/4 
and α2,3/6 linkages (Tailford et al. 2015).
Recent genome analyses have highlighted metabolic 
pathways responsible for the degradation of HMOs and 
mucin-type O-glycans in certain infant-derived bifido-
bacteria. With regards to HMO utilization it has been 
shown that B. bifidum and B. longum subsp. infantis can 
utilize many different HMOs directly (Asakuma et  al. 
2011; Garrido et al. 2016; Sela 2011; Ward et al. 2007). In 
contrast, B. breve and B. longum subsp. longum can only 
metabolize a small number of these directly, thus relying 
on cross-feeding strategies (Asakuma et  al. 2011; Egan 
et al. 2014; LoCascio et al. 2007; Ward et al. 2007). B. bifi-
dum is the only bifidobacterial species described so far 
to be able to utilize mucin-type O-glycans (Turroni et al. 
2010), and the products of (extracellular) mucin degrada-
tion constitute growth substrates for other (bifido)bac-
terial species, revealing that bifidobacteria can adopt a 
syntrophic strategy to access different substrates available 
in the gut (Egan et al. 2014; Turroni et al. 2018b).
The complex structural and functional heterogene-
ity of HMOs in mother’s milk is presumed to be essen-
tial in conferring the bifidogenic activity and associated 
health benefits to the host, yet it also represents the main 
limitation for the deliberate incorporation of HMOs in 
infant formulations (Akkerman et al. 2018). For this rea-
son alternative ways of recreating the beneficial effects of 
human milk have focused on the enzymatic production 
of other non-digestible, lactose-derived prebiotics, such 
as GOS produced by β-galactosidases that have transga-
lactosylation activities (Macfarlane et al. 2008).
Based on the above, the relevance of diet-based, lac-
tose-derived oligosaccharides (e.g. HMOs and GOS) in 
supporting bifidobacterial establishment and persistence 
in the gut is obvious, especially during early life when bifi-
dobacteria are particularly abundant (Milani et al. 2017). 
The current study focused on a survey and subsequent 
hydrolytic characterization of (selected) β-galactosidases 
identified from sequenced strains of bifidobacterial spe-
cies which have been previously shown to be members 
of the infant gut microbiota (i.e. B. breve, B. bifidum, B. 
longum subsp. longum and B. longum subsp. infantis) 
(Lewis and Mills 2017; Milani et  al. 2017; Turroni et  al. 
2012). Following comparative genome analysis, our anal-
ysis focused on a number of selected β-galactosidases of 
which hydrolytic capabilities were assessed for various 
β-galactoside-containing substrates.
Materials and methods
In silico genome analysis to identify putative 
β‑galactosidase‑encoding genes
For comparative purposes, genomic datasets, consist-
ing of 34 genome sequences (Table  1) from four repre-
sentative infant-derived bifidobacterial (sub)species (i.e. 
B. breve, B. bifidum, B. longum subsp. longum and B. 
longum subsp. infantis) were retrieved from GenBank 
(https ://www.ncbi.nlm.nih.gov/genba nk). Of the cor-
responding 34 bifidobacterial strains, we selected six 
strains as representative reference strains for our analy-
sis as their genome had been sequenced to completion 
and because these strains are available within our culture 
collection [i.e. B. breve UCC2003 (GenBank: CP000303), 
B. breve JCM 7017 (GenBank: CP006712), B. breve JCM 
7019 (GenBank: CP006713), B. bifidum LMG 13195 
(WGS: AMPL01000000), B. longum subsp. longum 
NCIMB 8809 (GenBank: CP011964) and B. longum 
subsp. infantis ATCC 15697 (GenBank: CP001095)]. 
The selected genomes were searched for predicted 
β-galactosidase-encoding genes on the basis of a func-
tional annotation supported by PFAM analysis (http://
pfam.xfam.org/), combined with information retrieved 
from the Cazy database (http://www.cazy.org). Predic-
tions were refined using comparative genome analysis 
with detection of orthologous β-galactosidase-encoding 
genes across genomes using BLASTP searches (Altschul 
et al. 1990). BLASTP alignments were performed using a 
stringency of 50% of identity across 50% of the length of 
the examined proteins, with a cut-off E-value of < 0.0001. 
Predicted β-galactosidase-encoding genes were then 
grouped in clusters of orthologs using the cd-hit pipe-
line (http://weizh ongli -lab.org/cd-hit/) with a clustering 
threshold of 70% identity across 90% of the correspond-
ing protein length (Bottacini et al. 2014).
Phylogenetic inference was conducted using the 
MEGA7 suite (http://www.megas oftwa re.net/). Protein 
sequence alignments were performed using the Mus-
cle module available within MEGA7 and the resulting 
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phylogenetic tree was built using the neighbour joining 
approach with statistical assessment based on 1000 boot-
strap replicates.
Growth conditions and strain manipulation
Bifidobacterial strains were cultured in de Man Rogosa 
and Sharpe (MRS) medium supplemented with cysteine-
HCl (0.05% w/v) and incubated at 37  °C degrees under 
anaerobic conditions using an anaerobic chamber (David-
son and Hardy, Belfast, Ireland). L. lactis strain NZ9000 
(University of Groningen, The Netherlands) was selected 
for cloning (de Ruyter et  al. 1996), overproduction and 
purification purposes as several bifidobacterial GH-
encoding genes had previously been successfully cloned 
and expressed in this host (James et al. 2016; O’Connell 
et  al. 2013; O’Connell Motherway et  al. 2013). L. lac-
tis NZ9000 was grown in M17 broth (Oxoid, UK) sup-
plemented with 0.5% glucose (GM17) at 30  °C degrees 
(Terzaghi and Sandine 1975). L. lactis NZ9000 cells car-
rying (suspected) recombinant plasmids were selected on 
GM17 agar containing chloramphenicol (Cm 5 µg ml−1), 
and supplemented with X-gal (5-bromo-4-chloro-3-in-
dolyl-ß-d-galactopyranoside) (40  µg  ml−1) to visually 
identify recombinant clones expressing β-galactosidase 
activity.
Chromosomal DNA was isolated from B. breve 
UCC2003, B. bifidum LMG 13195, B. longum subsp. 
longum NCIMB 8809 and B. longum subsp. infantis 
ATCC 15697 as previously described (O’Riordan and 
Fitzgerald 1998). Plasmid extraction from L. lactis was 
achieved using the Roche High Pure Plasmid Isolation 
Kit (Roche Diagnostics GmbH, Mannheim, Germany). 
For L. lactis an initial lysis step was included where 
cells are incubated in lysis buffer containing 30 mg ml−1 
of lysozyme for 30  min at 37  °C. Oligonucleotide PCR 
primers used in the study were synthesized by Eurofins 
(Ebersberg, Germany; Table  2). Standard PCRs were 
performed using Thermo Scientific Extensor Hi-Fidelity 
PCR Master mix (Thermo Scientific), while high fidelity 
PCR was achieved using Q5 High-Fidelity DNA Polymer-
ase (New England BioLabs, New Brunswick). PCR frag-
ments were purified with Roche High Pure PCR Product 
Purification Kit (Roche Diagnostics GmbH). Plasmid 
pNZ8150 was used as cloning and nisin-inducible 
expression vector. DNA fragments encompassing pre-
dicted β-galactosidase-encoding genes and the pNZ8150 
vector were restricted with specific restriction enzymes 
(Table 2) according to the supplier’s instructions (Roche 
Diagnostics, East Sussex, United Kingdom). Ligation was 
achieved with T4 DNA ligase according to the manufac-
turer’s instructions (Promega, Wisconsin, USA, world-
wide.promega.com). Electroporation of (ligated) plasmid 
DNA into L. lactis was performed as described previ-
ously (Wells et al. 1993).
Protein overproduction and purification
For bifidobacterial protein overproduction 0.4  ml of 
M17 broth supplemented with 0.5% glucose was inocu-
lated with a 2% inoculum of L. lactis strain harbouring 
the pNZ8150 cloning vector containing a (predicted) 
β-galactosidase-encoding gene, and cultivated at 30  °C 
until the culture reached an Optical Density  (OD600 nm) of 
0.5. At this point targeted protein expression was induced 
by the addition of filter sterilised cell free supernatant 
of a nisin-producing strain L. lactis NZ9700 (0.2% v/v) 
Table 1 Bifidobacterial strains used for  comparative 
analyses
Species Strain Accession number WGS
B. bifidum JCM 1254 BBBT00000000
B. bifidum DSM 20215 –
B. bifidum DSM 20456 JDUM00000000
B. bifidum NCIMB 41171 AKCA01000000
B. bifidum PRL2010 CP001840
B. bifidum S17 CP002220
B. bifidum BGN4 CP001361
B. bifidum IPLA20015 AMPM01000000
B. bifidum LMG 11041 JGYO01000000
B. bifidum LMG 13195 AMPL01000000
B. breve 2L AWUG00000000
B. breve JCM 7019 CP006713
B. breve UCC2003 CP000303
B. breve 31L AWUF01000000
B. breve NCFB 2258 CP006714
B. breve S27 CP006716
B. breve 12L CP006711
B. breve JCM 7017 CP006712
B. breve JCP 7499 AWSX01000000
B. longum subsp. infantis ATCC 15697 CP001095
B. longum subsp. infantis EK3 JNWB01000000
B. longum subsp. infantis 157F AP010890
B. longum subsp. infantis CCUG 52486 ABQQ01000000
B. longum subsp. longum NCIMB 8809 CP011964
B. longum subsp. longum EK13 JNWD01000000
B. longum subsp. longum F8 FP929034
B. longum subsp. longum KACC 91563 CP002794
B. longum subsp. longum VMKB44 JRWN01000000
B. longum subsp. longum ATCC 55813 ACHI01000000
B. longum subsp. longum BBMN68 CP002286
B. longum subsp. longum JCM 1217 AP010888
B. longum subsp. longum LMG 13197 JGYZ01000000
B. longum subsp. longum JDM301 CP002010
B. longum subsp. longum CECT 7347 CALH01000000
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(de Ruyter et al. 1996) and incubation was continued at 
30 °C for 90 min. Cells were harvested by centrifugation 
(5000  rpm for 10  min), the obtained pellet was recov-
ered in lysis buffer (50 mM sodium phosphate buffer, pH 
8; 300 mM NaCl; 10 mM Imidazole) and cells were dis-
rupted by bead beating (1 min, three times). Cell debris 
was removed by centrifugation (15,000  rpm for 20  min 
at 4  °C) and the resulting supernatant, representing the 
crude cell extract, was used for (His-tagged) protein 
purification using a nickel-nitrilotriacetic acid column 
(Qiagen GmbH) according to the manufacturer’s instruc-
tions (QIAexpressionist, June 2003). Elution fractions 
were analysed by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE), as described previously (Laemmli 1970), on 
Table 2 Oligonucleotide primers used in this study
Gene Primer Sequence Restriction 
enzymes
Bbr_0010 Fw tgcatcGATAT Ccatcaccatcaccatcaccatcaccatcacatgcatcaccatcaccatcaccatcacc EcoRV
Rv tgcgcaTCT AGA tcagatgagttcgagtgtcac XBaI
Bbr_0285 Fw tgcatcGAT ATC atgcatcaccatcaccatcaccatcaccatcacatggagcgaatccaatacccc EcoRV
Rv tgcgcaTCT AGA tcacacctgcacgtagccg XBaI
Bbr_0310 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatggggacgacaggacacagc EcoRV
Rv tgcgcaTCT AGA tcaactcttttcgattgcg XBaI
Bbr_0420 Fw tgcatcCCC GGG catcaccatcaccatcaccatcaccatcacatgactactcgtagagc XmaI
Rv ctcgaaTCT AGA ctagcaggacgttttagcg XBaI
Bbr_0529 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatggaacatcgcgaattcaag EcoRV
Rv tgcgcaTCT AGA ttacagctttaccaccagcac XBaI
Bbr_1552 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatgaacacaaccgacgatcag EcoRV
Rv tgcgcaTCT AGA tcagatgagttcgaggttcac XBaI
Bbr_1689-1690 Fw tgcatcCAG CTG catcaccatcaccatcaccatcaccatcacatgagcaagcagaacgattg PvuII
Rv tgcgcaTCT AGA gctggcatcttcctgaacg XBaI
B7017_2031 Fw tgcatcGAA TTC catcaccatcaccatcaccatcaccatcacatgaccgacaccatggcacacacacaacc EcoRI
Rv tgcatcTCT AGA ctgatgatgaaggatgactgaagccg XBaI
B216_06500 Fw tgcatc ATT TAA AT atg catcaccatcaccatcaccatcaccatcac gtcaataccgttagggttgt SwaI
Rv tgcatc TCT AGA cccggggagactcgcgagagt XBaI
B216_08266 Fw tgcatcATT TAA ATcatcaccatcaccatcaccatcaccatcacatgagtaaacgcagaaagcacag SwaI
Rv tgcgcaTCT AGA gtatgtcgcgtgtcaccg XBaI
B216_08730 Fw tgcatcGAT ATC atgcatcaccatcaccatcaccatcaccatcacgtgcgcgcgcgacgtgactttg EcoRV
Rv tgcatc TCT AGA aacgttgaaatagagccggaaac XBaI
B216_09411 Fw tgcatc ATT TAA ATatg catcaccatcaccatcaccatcaccatcac ttcattccccggtactacg SwaI
Rv tgcatc TCT AGA atccgatacccgtacccgtg XBaI
B216_09623 Fw tgcatcATT TAA ATcatcaccatcaccatcaccatcaccatcacatgaacacaaccgacgatcagc SwaI
Rv tgcgcaTCT AGA atgagcgagaggacctggcg XBaI
B8809_0321 Fw tgcatcATT TAA ATcatcaccatcaccatcaccatcaccatcacatgactactcatagagcatttag SwaI
Rv tgcatc TCT AGA cattctagcgcggtttag XBaI
B8809_0415 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatggaacgtaaagagttcaagtgg EcoRV
Rv tgcatcTCT AGA ccgttgggtaattaggcgct XBaI
B8809_0611 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatgacagacgtcacacatgtcg EcoRV
Rv tgcatc TCT AGA tgcacggtggactatcggatc XBaI
B8809_1361 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatgcagcatcccatccccaccac EcoRV
Rv tgcatc TCT AGA cagcacgataaagaagctccctcg XBaI
Blon_2016 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatggaacatagagcgttcaagt EcoRV
Rv tgcatcTCT AGA cggctccctgctgcgatga XBaI
Blon_2123 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatggtgcgtgcgcgacgtgactt EcoRV
Rv tgcatcTCT AGA accatgtacgtcggcaccgt XBaI
Blon_2416 Fw tgcatcGAT ATC catcaccatcaccatcaccatcaccatcacatgaccgacaccatggcaca EcoRV
Rv tgcatcTCT AGA cggttgctgacttgggatat XBaI
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a 12.5% polyacrylamide (PAA) gel. After electrophoresis, 
PAA gels were fixed and stained with Coomassie brilliant 
blue to identify fractions containing the purified protein. 
For molecular weight estimation of (purified) proteins 
the Prestained Protein Marker, Broad Range (7–175 kDa) 
was used (New England BioLabs, Hertfordshire, United 
Kingdom).
Beta‑galactosidase assay: crude cell extract
Colorimetric and spectrophotometric assay was per-
formed to evaluate the hydrolytic activity of predicted 
β-galactosidases towards the artificial substrate O-nitro-
phenyl β-d-galactopyranose (ONPG assay). This assay 
was performed at 30  °C according to a previously pub-
lished protocol (Miller, Cold Spring Harbor, 1972). Fol-
lowing the development of a yellow color the reaction 
was terminated by the addition of 250 µl 1 M sodium car-
bonate. This was followed by measurement of absorbance 
at a wave length of 420 nm. Calculation of β-galactosidase 
activity was performed according to the following for-
mula: β-gal unit = 1000*OD420 nm/Time*V*OD600 nm, with 
incubation time of 5 min (or longer if required) and vol-
ume of resuspended pellet (V) of 0.05 ml.
Hydrolysis assay and product analysis
Hydrolysis assays of β-galactosidase activity were per-
formed on the following commercially available sub-
strates: lactose, lactulose, two different galactotrioses 
(Galβ1-4Galβ1-4Gal and Galα1-3Galβ1-4Gal), two 
different galactobioses (Galβ1-6Gal and Galβ1-4Gal), 
lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 
2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL). 
The hydrolysis assays were performed using the follow-
ing conditions: 250  µl enzyme solution was incubated 
with 0.1 mg ml−1 of a particular carbohydrate in MOPS 
[3-(N-morpholino) propanesulfonic acid] buffer pH 6.5 
in a total volume of 1 ml at 37 °C. Aliquots of 250 μl were 
collected after 1, 3 and 24  h from the start of the reac-
tion and following collection samples were immediately 
heated at 80 °C for 5 min in order to terminate the reac-
tion, after which they stored at − 20 °C until analysis by 
high-performance anion-exchange chromatography with 
pulsed amperometric detection (HPAEC-PAD) employ-
ing a CarboPac PA1 (Thermo Scientific) analytical-anion 
exchange column (dimensions, 250  mm by 4  mm) with 
a CarboPac PA1 (Thermo Scientific) guard column 
(dimensions, 50 mm by 4 mm) and a detector (ED40) in 
the pulsed amperometric detection PAD mode (Dionex, 
Thermo Scientific). Elution was performed at a constant 
flow rate of 1.0 ml min−1 at 30 °C using the following elu-
ents for the analysis: (A) 200 mmol NaOH, (B) 100 mmol 
NaOH, 550 mmol sodium acetate (NaAC), and (C) Milli-
Q water. The elution gradient is reported in Table  3. 
The obtained data sets were then analysed employing 
CHROMELEON software Ver.6.70 (Dionex, Thermo 
Scientific).
Results
Comparative analysis of β‑galactosidase‑encoding genes
In order to identify putative β-galactosidase-encoding 
genes of infant-associated bifidobacterial strains, we ini-
tially selected the genomes of six strains to act as rep-
resentatives for four bifidobacterial (sub) species (see 
“Materials and methods” section) that are typically prev-
alent and abundant in the (healthy) infant gut microbiota.
Putative β-galactosidase-encoding genes were identi-
fied on the genome sequence of each of these six refer-
ence strains (representing four species) based on manual 
searches and cross-validation of the obtained result 
with PFAM searches and Cazy database (see “Mate-
rials and methods”). The obtained list of predicted 
β-galactosidase-encoding genes was then used for further 
comparative analyses, aimed at identifying homologous 
genes across a more extensive set of 34 bifidobacterial 
genomes, belonging to the same (sub)species as the ref-
erence set (Table 1). Employing this comparative search 
approach we established that the total number of pre-
dicted GH2 and GH42 β-galactosidase-encoding genes 
encoded by (34 representatives of ) these four bifidobac-
terial species is 137, of which 44, 45 and 48 were assigned 
to B. breve, B. bifidum and B. longum subsp. longum spp., 
respectively (Additional file 1: Table S1).
Comparative sequence analysis and phylogeny 
of predicted β‑galactosidase genes
To establish if a putative β-galactosidase-encoding gene 
is represented by homologs across other strains or (sub)
species, we organized the 137 identified β-galactosidases 
in 18 orthologous families (here referred as clusters 
based on a cut-off value of 70% of similarity over 90% of 
sequence length; see “Materials and methods”) (Addi-
tional file  1: Figure S1). This analysis revealed that 
members of each of the 18 orthologous clusters are vari-
ably distributed across a given species, where certain 
β-galactosidases seem to be more species-specific (e.g. 
Table 3 Elution gradient used in HPAEC-PAD
Minute Concentration NaOH 
(mmol l−1)
Concentration 
NaAC (mmol l−1)
0–50 100 0
50–51 0 0
51–56 0 16
56–61 0 100
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Clusters 1–3 for B. bifidum, Clusters 4–6 for B. breve and 
Clusters 7–8 for B. longum subsp. longum), while others 
are present among all members of the four (sub)species 
(e.g. Cluster 15) (Fig. 1 and Additional file 1: Table S1).
As mentioned above comparative sequence analy-
sis organized the 137 identified β-galactosidases into 
18 clusters of orthology (Fig.  1). A subsequent analysis 
was carried out in order to establish the phylogenetic 
relationships between bifidobacterial β-galactosidases. 
This analysis resulted in the generation of a phyloge-
netic tree which subdivided these 137 genes into two 
distinct clades, corresponding to members that either 
belong to GH family 2 or GH family 42 (Fig. 2). Within 
these GH2 and GH42 clades, our analysis revealed that 
the β-galactosidase-encoding genes are further distrib-
uted across 14 distinct phylogenetic groups (or subclades 
defined by nodes of bootstrap value above 90%), where 
genes from strains belonging to the same species often 
cluster together (Fig. 2).
Cloning of bifidobacterial β‑galactosidase‑encoding genes
Based on the outcome of the phylogenetic analyses, a 
total of 20 most diverse β-galactosidases (present in the 
six representative genomes available within our culture 
collection, while also considering practical limitations 
of cloning this large number of genes) were selected as 
candidates for further experimental validation, which 
in most cases locate in separate branches of the phylo-
genetic tree (Fig.  3a). This selection therefore captures 
much of the observed diversity among the identified 
(putative) β-galactosidases (Fig.  3). Notably, of these 20 
selected β-galactosidases, four (corresponding to locus 
Fig. 1 Comparative analysis of β-galactosidases in infant-derived bifidobacterial (sub)species. Heatmap showing presence (red) and absence (blue) 
of 18 clusters of β-galactosidase-encoding genes across the 34 bifidobacterial representatives of B. breve, B. bifidum, B. longum subsp. longum and 
B. longum subsp. infantis. A blue arrow highlights Cluster 15, which is present across members of all the four (sub)species, while blue, green and 
brown colours identify clusters observed only in B. bifidum, B. breve and B. longum species, respectively
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tags B216_08266, Bbr_0529, B8809_0415 and Blon_2016) 
are orthologous genes within Cluster 15, of which mem-
bers are present across all four infant-derived bifidobac-
terial (sub)species, while the remaining 16 selected genes 
are present only within certain (sub)species (Fig. 3b).
In order to investigate if the 20 putative β-galactosidase-
encoding genes as selected above do in fact encode this 
enzymatic activity, cloning and (over)expression of each 
of these bifidobacterial genes in Lactococcus lactis was 
performed. The 20 β-galactosidase-encoding genes were 
therefore amplified by PCR using primer pairs, one of 
which included a six His-tag-encoding sequence (to aid in 
subsequent purification), and cloned into a nisin-induc-
ible expression vector in L. lactis (see “Materials and 
methods”). Two out of the 20 predicted β-galactosidase-
encoding genes (corresponding to locus tags B216_06500, 
B216_09411) appeared to be unclonable in L. lactis (as 
based on multiple failed attempts). One explanation 
Fig. 2 Phylogenomics of β-galactosidases. Neighbour-joining tree based on the alignment of 137 putative β-galactosidases identified across 34 
members of infant-derived bifidobacterial (sub)species. A red circle highlights the genes used for experimental assessment in this study, while blue 
and orange squares identify those genes of which involvement in the assimilation of GOS and HMOs have been reported in literature. Circles on 
the phylogenetic tree highlight nodes with bootstrap values above 90% and dark blue circles identify the 14 phylogenetic groups defined by our 
analysis
Fig. 3 Distribution of β-galactosidases selected for functional assessment across the five bifidobacterial reference strains. a Similarity plot showing 
the percentage of similarity of the 20 selected β-galactosidases across the reference strains (cut-off of 70% of identity over 90% of protein length). 
For each gene the relative cluster of appartenance from comparative genomics is also indicated. b Hierarchical clustering analysis showing the 
co-occurrence of the 20 selected β-galactosidases and their cluster of orthology across the reference genomes and bifidobacterial (sub)species
(See figure on next page.)
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ClusterID Locus_tag Bbr_0010
Cluster5 Bbr_0010 Bbr_0285
Cluster17 Bbr_0285 Bbr_0310
Cluster18 Bbr_0310 Bbr_0420
Cluster13 Bbr_0420 Bbr_0529
Cluster15 Bbr_0529 Bbr_1552
Cluster6 Bbr_1552 Bbr_1689-90
Cluster4 Bbr_1689-90 B7017_2031
Cluster14 B7017_2031 B216_09411
Cluster2 B216_09411 B216_08730
Cluster12 B216_08730 B216_06500
Cluster12 B216_06500 B216_08266
Cluster15 B216_08266 B216_09623
Cluster3 B216_09623 B8809_0321
Cluster13 B8809_0321 B8809_0415
Cluster15 B8809_0415 B8809_0611
Cluster7 B8809_0611 B8809_1361
Cluster8 B8809_1361 Blon_2016
Cluster15 Blon_2016 Blon_2123
Cluster12 Blon_2123 Blon_2416
Cluster14 Blon_2416
Cluster15
B. breve + B. bifidum +
B. longum (sub)species
Cluster12
B. longum (sub)species
Cluster13
B. breve + B. longum
B. breve
B. bifidum
B. longum subsp. longum
B. longum subsp. infantis
100
90
80
70
Cluster14
B. breve + B. longum
a
b
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could be the plasmid instability due to the (size of the) 
inserted gene, or toxicity of their products in the clon-
ing host. In one case (i.e. Blon_2123 from B. longum 
subsp. infantis ATCC 15697), we found that the cloned 
gene contained a stop codon located 100 bp downstream 
of the start of the gene, thus making this a pseudogene. 
It is worth mentioning that BLAST analysis of this par-
ticular sequence against the deposited genome sequence 
of B. longum subsp. infantis ATCC 15697 showed that 
the publicly available sequence does not contain a stop 
codon at this point, suggesting that this mutation may 
be unique to our stock of B. longum ATCC 15697 (NB. 
the chromosomal sequence of this stock was verified by 
sequence analysis of a PCR product that encompassed 
the relevant section of Blon_2123). The obtained L. lac-
tis transformants (or at least a proportion of the colo-
nies corresponding to a given transformation) from the 
remaining 17 cloning efforts were in 14 cases shown to 
form easily identifiable blue colonies on plates including 
the chromogenic substrate X-gal (yet in the absence of 
the inducer nisin) (Table 4). This result clearly indicates 
that the majority of the cloned genes indeed encodes 
a β-galactosidases active on this artificial substrate. In 
three cases (i.e. corresponding to the cloning of genes 
with locus tags Bbr_0285, Bbr_0310 and B7017_2031) 
transformants only formed white colonies (though they 
contained the expected recombinant plasmid as verified 
by sequencing), suggesting that either the encoded prod-
uct does not encode a β-galactosidase capable of cleaving 
X-Gal, or that the cloned gene was not (highly) expressed 
or its product not properly folded (Table  4). The plas-
mid content of a selection of positively identified clones 
for each cloning was sent for sequencing to validate 
sequence integrity of the cloned gene. In summary, of the 
total of 20 selected (putative) β-galactosidase-encoding 
genes, 17 were successfully cloned (as an intact gene), of 
which 14 turned out to encode β-galactosidase activity as 
based on the applied X-gal plate assay.
β‑galactosidase assays: crude cell extract
In order to determine if the products of the 17 cloned 
genes were active on substrates other than or in addi-
tion to X-gal, β-galactosidase assays were conducted 
using crude cell extracts obtained from individual, 
nisin-induced cultures of L. lactis in which a predicted 
β-galactosidase-encoding gene had been cloned (Addi-
tional file 1: Figure S2). Out of the 17 different crude cell 
extracts tested, nine were shown to exhibit high activity 
against the artificial substrate ONPG (between 5000 and 
14,000 Miller units) (Fig. 4). In addition, five crude cell-
free extracts were demonstrated to display a relative low 
level of enzymatic activity (between 400 and 2000 Miller 
units) to cleave this ONPG substrate, while the remain-
ing three crude cell-free extracts (corresponding to the 
expressed proteins specified by Bbr_0285, Bbr_0310 and 
Bbr_1689/1690) failed to show hydrolytic activity against 
this substrate (baseline set at 400 Miller units) (Fig.  4). 
It is worth mentioning that Bbr_0285 and Bbr_0310 
Table 4 Hydrolysis performance of  the  17 cloned β-galactosidases tested on  substrates lactose, lactulose 
and d-galactotriose
ClusterID Locus_tag X-GAL assay
ONPG crude
extracts 1h 3h 24h 1h 3h 24h 1h 3h 24h
B. breve  UCC2003 Cluster 5 Bbr_0010
Cluster 17 Bbr_0285
Cluster 18 Bbr_0310
Cluster 13 Bbr_0420
Cluster 15 Bbr_0529
Cluster 6 Bbr_1552
Cluster 4 Bbr_1689-90
B. breve  JCM 7017 Cluster 14 B7017_2031
B. bifidum LMG 13195 Cluster 15 B216_08266
Cluster 12 B216_08730
Cluster 3 B216_09623
B. longum subsp. longum 8809 Cluster 13 B8809_0321
Cluster 15 B8809_0415
Cluster 7 B8809_0611
Cluster 8 B8809_1361
B. longum subsp. infantis ATCC 15697 Cluster 15 Blon_2016
Cluster 14 Blon_2416
Lactose  Lactulose
 D-Galactotriose
(Galβ1-4Galβ1-4Gal)
Key to colour coding: Substrate hydrolysis observed (green), no hydrolysis (white) and substrate not assayed (grey). Results of X-gal and ONPG assays are also reported 
for comparative purposes
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also did not form blue colonies on plates, thus provid-
ing further confirmation of their presumed inactivity as 
β-galactosidases (at least on the substrates tested, though 
lack of activity may also be due to lack of expression or 
protein misfolding).
Protein overproduction, purification and hydrolysis assay
All cloned (putative) β-galactosidase-encoding genes 
were then utilized for protein overproduction and sub-
sequent His6-tagged protein purification using the L. 
lactis nisin-inducible protein production system (see 
“Materials and methods”). In order to verify the success 
of these steps, individually expressed and purified pro-
teins were visualised by SDS-PAGE analysis followed 
by staining with Coomassie Brilliant Blue (Additional 
file  1: Figure S2). In order to assess substrate specific-
ity of each of the 17 cloned (predicted) bifidobacte-
rial β-galactosidases, qualitative hydrolysis assays by 
HPAEC-PAD analysis were performed using a number 
of (β-)galactosidic linkage-containing carbohydrates. The 
(putative) β-galactosidases were first tested for hydrolytic 
activity towards lactose, lactulose and β-d-galactotriose 
(Galβ1-4Galβ1-4Gal) (Table  4). The obtained results 
demonstrate that the purified proteins exhibited vary-
ing ability to cleave these different sugars. In the reac-
tion with lactose the best activity (i.e. complete or partial 
hydrolysis of the substrate observed within the first hour 
of reaction) was exhibited by the proteins corresponding 
to Bbr_0010, Bbr_0529 and Bbr_1552 (all from B. breve), 
B216_08266 (from B. bifidum), B8809_0415, B8809_0611 
and B8809_1361 (all from B. longum subsp. longum), and 
Blon_2016 (from B. longum subsp. infantis) (Table  4). 
When the reaction was performed with lactulose the 
most active proteins were those corresponding to locus 
tags Bbr_0529, Bbr_1552, B216_08266, B8809_0415, 
B8809_1361, Blon_2016 and Blon_2416 (Table 4). When 
Fig. 4 ONPG assay. Barplot showing the result of the ONPG assay performed on crude cell-free extracts of the 17 successfully cloned 
β-galactosidases. Crude cell-free extracts showing relative high level of enzymatic activity are indicated in red
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the hydrolysis reaction was performed with the sub-
strate β-d-galactotriose (Galβ1-4Galβ1-4Gal), the pro-
teins corresponding to locus tags Bbr_0420, Bbr_0529, 
B216_08266, B216_08730, B8809_0321, B8809_0415, 
Blon_2016 and Blon_2416 were shown to hydrolyse the 
substrate within the first hour of the applied reaction 
conditions (Table  4). Following these three tests it was 
decided to eliminate the proteins corresponding to locus 
tags Bbr_0285, Bbr_0310, Bbr_1689/90, B216_8730, 
B216_09623 and B7017_2031 from further analyses 
because they were shown to be unable to hydrolyse any 
of the sugars tested. Notably, among these negatives are 
Bbr_0285 and Bbr_0310, which also did not show activ-
ity towards X-gal or ONPG substrates (Table  4; Fig.  4). 
In addition Bbr_1689/90, B216_09623 and B7017_2031 
showed discordant activity towards hydrolytic activ-
ity towards X-gal, ONPG and lactose substrates. For 
this reason we decided to test their hydrolytic activity 
also on crude cell extract (which represents an unpuri-
fied enzyme; our purification method could have caused 
inactivation of the enzyme). Absence of protein expres-
sion was not considered to be the reason for the lack of 
activity of these enzymes because all these proteins were 
successfully overproduced and purified (Additional file 1: 
Figure S2). Based on the results of the hydrolysis assay on 
crude cell extracts, B216_09623 and B7017_2031 were 
shown to be capable of lactose hydrolysis, thus suggest-
ing that the protein purification may have negatively 
affected their activity. Hydrolysis assays employing the 
remaining eleven β-galactosidases were then performed 
utilizing commercially available β-galactosyl-containing 
structures (including HMOs and GOS) as potential sub-
strates. In the case of galactobiose (Galβ1-6Gal), clear 
hydrolysis activity was obtained when the reaction was 
performed with the proteins corresponding to locus 
tags Bbr_0529, Bbr_1552, B216_08266, B8809_0415 and 
Blon_2016. When the substrate galactotriose Galα1-
3Galβ1-4Gal was used, no activity was detected within 
24 h for any of the proteins tested, whereas four proteins 
(corresponding to Bbr_0420, Bbr_1552, B8809_0321, 
Blon_2416) were shown to be able to cleave galactobi-
ose Galβ1-4Gal (Table  5). In order to further charac-
terize the identified predicted β-galactosidases, their 
ability to hydrolyse the following carbohydrates, repre-
senting a selection of (β-linked galactose-containing) 
HMOs: lacto-N-tetraose (LNT), lacto-N-neotetraose 
(LNnT), 2′-fucosyllactose (2′-FL) and 3-fucosyllactose 
(3-FL) (Table  5). In the reaction with LNT the highest 
activity (positive within the first hour of reaction) was 
exhibited by the proteins corresponding to locus tags 
Table 5 Hydrolysis performance of  the  11 selected β-galactosidases tested on  galactobiose, galactotriose, LNT, LNnT, 
2′-FL and 3-FL
Key to colour coding: Substrate hydrolysis observed (green), no hydrolysis (white)
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Bbr_0529 and Bbr_1552 (from B. breve), B216_08266 
(from B. bifidum), B8809_0415, (from B. longum subsp. 
longum), and Blon_2016 (from B. longum subsp. infantis) 
(Table 5). When the reaction was performed with LNnT 
as a substrate, the most active proteins were those cor-
responding to locus tags Bbr_0010, Bbr_0529, Bbr_1552, 
B216_08266, B8809_0415, B8809_0611, B8809_1361 and 
Blon_2016 (Table  5). When the hydrolysis reaction was 
performed with the substrate 2′-FL, it was found that 
none of the proteins is active on this substrate (Table 5). 
The last sugar tested was 3-FL, and in this case the most 
active proteins were Bbr_0420, Bbr_0529, B216_08266, 
B8809_0321, B8809_0415, B8809_0611, B8809_1361 and 
Blon_2016 (Table 5).
Discussion
In the current work we investigated β-galactosidase 
enzymes belonging to four bifidobacterial species B. 
breve, B. bifidum, B. longum subsp. longum and B. 
longum subsp. infantis, all of which are commonly found 
in healthy, breast-fed infants. Our analysis clearly shows 
that multiple distinct β-galactosidases are encoded by 
these infant-derived bifidobacterial species (Additional 
file  1: Table  S1) with a partial overlap between their 
hydrolytic activities (Tables  4 and 5). Notably, for some 
of the identified β-galactosidases the involvement in uti-
lization of galacto-oligosaccharides and/or host-derived 
glycans has previously been reported (Additional file  1: 
Table  S1). Of note, some of the clusters from our com-
parative analysis appeared to be species specific, suggest-
ing that certain β-galactosidase encoding genes are only 
found within certain species. For example the enzymes 
belonging to Clusters 1, 2, 3, 6 and 9 contain a wide range 
of B. bifidum β-galactosidases which represent homologs 
of BbgIII (NCIMB 41171), BbgI (NCIMB 41171), BbgIV 
(NCIMB 41171), BIF2 (DSM 2015) and BIF1 (DSM 
20215), respectively. Notably, these enzymes have pre-
viously been reported to be capable of GOS synthesis 
(Additional file  1: Table  S1) (Goulas et  al. 2007; Miwa 
et al. 2010; Moller et al. 2001).
Our comparative analysis was used as a guide to 
select 20 candidates to be used for further assessment of 
β-galactosidase activity towards a number of substrates 
including a range of selected β-galactosyl-containing 
structures. Cloning efforts of the selected genes resulted 
in the successful overexpression and purification of 17 
presumed β-galactosidases, of which hydrolytic activ-
ity was further assessed on a variety of substrates. The 
obtained findings revealed that the majority of the 
expressed enzymes indeed exhibit β-galactosidase activ-
ity. However, these β-galactosidases clearly differ from 
each other in their substrate specificity, since some of the 
enzymes are active on nearly all tested substrates, while 
others appear to be quite specific and merely hydrolyse 
one or two substrates.
Of note, the enzymes that are capable of hydrolysing 
the broadest range of selected substrates are members of 
Cluster 15 and are also widespread across the four (sub)
species (i.e. Bbr_0529, B216_08266, B8809_0415 and 
Blon_2016), suggesting that these genes encode con-
served β-galactosidase activities. Besides, enzymes of 
Cluster 15 appear to be homologous to the previously 
identified BbgII (from B. bifidum NCIMB 41171), which 
is capable of both GOS hydrolysis and synthesis (Goulas 
et al. 2007; Miwa et al. 2010; Moller et al. 2001) (Fig. 1). 
Notably, some of the β-galactosidases represented by this 
cluster have previously been shown to be involved in the 
utilization of either GOS and HMOs (Additional file  1: 
Table S1). In particular, it has been shown that Blon_2016 
from B. longum subsp. infantis ATCC 15697 represents 
a β-galactosidase possessing hydrolytic activity towards 
LNT and LNnT, as well as GOS (Garrido et  al. 2013), 
which is indeed confirmed by our observations (Tables 4 
and 5).
Another member of Cluster 15 is the β-galactosidase 
encoded by Bbr_0529, which is required for the utiliza-
tion of GOS and certain HMOs by B. breve UCC2003 
(James et  al. 2016; O’Connell Motherway et  al. 2013), 
being consistent with our observed hydrolytic activi-
ties towards the majority of tested substrates including 
galactobiose, galactotriose, but also the central moie-
ties of type I and type II HMOs (Tables 3, 4). As type I 
chains represent the most abundant HMO core structure 
in human milk (Urashima et al. 2012), the prevalence of 
Cluster 15 members across all four infant-derived bifi-
dobacterial (sub)species (Fig. 3b) and observed ability to 
cleave LNT (but also LNnT) (Table 4) supports their rel-
evance to bifidobacteria in obtaining access to substrates 
derived from a human milk-based diet.
Surprisingly, one of the β-galactosidases whose prod-
uct was shown to be incapable of hydrolysing lactose 
or lactulose is Bbr_0420, which was instead shown to 
be active towards d-galactotriose Galβ1-4Galβ1-4Gal 
(Table  4). Previous studies established that Bbr_0420, 
a β-galactosidase which is upregulated when B. breve 
UCC2003 is grown on purified GOS (O’Connell Moth-
erway et al. 2013), seems to be dedicated to the hydroly-
sis of d-galactotriose, which in turn is produced from 
the extracellular degradation of potato galactan in this 
strain (O’Connell Motherway et  al. 2011). The tran-
scription of this gene is, however, not induced when B. 
breve UCC2003 is grown on lactose and certain HMOs 
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(e.g. LNT or LNnT) (James et  al. 2016). Bbr_0420 from 
B. breve UCC2003 and its homologue B8809_0321 from 
B. longum subsp. longum NCIMB 8809 (both belonging 
to Cluster 13) were shown here to hydrolyse galactobiose 
(Galβ1-4Gal) and galactotriose (Galβ1-4Gal-β1-4Gal), 
but incapable of hydrolysing either LNT or LNnT. This 
suggests that they represent β-galactosidases with a nar-
row substrate specificity, which is directed towards β1,4 
galactosidic links (Tables  4, 5). Interestingly, a recent 
study has associated a homolog corresponding to this 
β-galactosidase and located within the galactan cluster of 
B. longum AH1206 (BL1206_0411) with the persistence 
of this strain in the GIT tract (Maldonado-Gomez et al. 
2016). This finding represents another indication of the 
role played by β-galactosidases and their dietary galac-
tose-containing substrates in promoting bifidobacterial 
colonization.
Notably, purified Bbr_0010 from B. breve UCC2003 
has previously been reported to hydrolyze lactose and 
LNnT (James et  al. 2016), while Bbr_1552 represents 
a β-galactosidase with a broader substrate specificity, 
being involved in the hydrolysis of GOS, as well as lac-
tose, LNT and LnNT in this strain (James et  al. 2016; 
O’Connell Motherway et  al. 2013), which is also con-
sistent with our observations. Interestingly, a previ-
ous study employing a Tn5-based random mutagenesis 
system in B. breve UCC2003 identified Bbr_0010 as the 
main β-galactosidase responsible for lactose utilization in 
this strain (Ruiz et  al. 2013). Based on our analysis this 
enzyme does indeed hydrolyse lactose (as well as LNnT) 
and the corresponding gene is conserved across B. breve 
(as Cluster 5 members).
Two interesting cases are constituted by B8809_0611 
(Cluster 7) and B8809_1361 (Cluster 8) from B. longum 
subsp. longum NCIMB 8809 as these two β-galactosidases 
show similar hydrolytic profile and are particularly active 
towards LNnT (type II chain) despite being member of 
two different clusters (Tables 4 and 5). Cluster 7 member 
Blon_2334 from B. longum subsp. infantis ATCC 15697 
has been described as a β-galactosidase responsible for 
degradation of lactose and type II HMOs, but not type I 
HMOs (Yoshida et al. 2012), being consistent with what 
we observed for B8809_0611. In contrast, B8809_1361, 
which shows a hydrolytic profile similar to Blon_2334 
and B8809_0611, belongs to a different cluster (Cluster 
8). Finally, B8809_1361 is only present in certain strains 
of B. longum subsp. longum, and perhaps constitutes an 
auxiliary β-galactosidase responsible for degradation of 
lactose and type II HMOs in this subspecies (Additional 
file 1: Table S1).
In conclusion, the information collected in this study 
highlights the importance of GHs in bifidobacterial 
saccharolytic metabolism, in particular β-galactosidases 
which are involved in the utilization of a range of sub-
strates such as lactose, HMOs, and GOS, found as part of 
the milk-based infant diet. The qualitative assay presented 
in this study provides a clear insight on the diversity of 
β-galactosidases in terms of substrate specificity. In fact, 
some appear to be more specialized towards milk-based 
substrates, while others are specific for plant-derived sub-
strates. Therefore, the findings presented here constitute 
a solid foundation for future studies on bifidobacterial 
β-galactosidases and further investigation on the role of 
milk-derived substrates in establishing bifidobacterial pre-
dominance in the infant GIT.
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Additional file 1: Table S1. List of bifidobacterial genes used for com-
parative purposes. Figure S1. In silico analysis and functional characteriza-
tion of β-galactosidases. Figure S2. SDS-PAGE of purified proteins.
Authors’ contributions
DvS, MS and MOM conceived the study. VA, JOS and MOM performed the 
experiments with the help of BS and CL. FB performed the bioinformatics 
analyses. DvS, FB and VA wrote the manuscript. All authors read and approved 
the final manuscript.
Author details
1 APC Microbiome Ireland, University College Cork, Western Road, Cork, 
Ireland. 2 School of Microbiology, National University of Ireland, Western Road, 
Cork, Ireland. 3 FrieslandCampina, Amersfoort, The Netherlands. 
Acknowledgements
We thank Dr. Bas Kuiper and Dr. Eric Benjamins for their support in performing 
this study.
Competing interests
AV, FB, JOS, MOM and DvS have no competing interests. MS, BS, and CL are 
employees of Friesland Campina.
Availability of data and materials
The data supporting the conclusions of this article are available and included 
within the article.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Funding
This work was financially supported by FrieslandCampina. DvS, VA, FB and 
MOM are members of APC Microbiome Ireland, which is a research centre 
funded by Science Foundation Ireland (SFI), through the Irish Government’s 
National Development Plan. The authors and their work were supported by 
SFI (Grant SFI/12/RC/2273), FEMS Research Grant FEMS-RG-2016-0103 and 
HRB (Grant No. 513 PDTM/20011/9).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Page 14 of 15Ambrogi et al. AMB Expr             (2019) 9:9 
Received: 22 December 2018   Accepted: 11 January 2019
References
Akkerman R, Faas MM, de Vos P (2018) Non-digestible carbohydrates in infant 
formula as substitution for human milk oligosaccharide functions: effects 
on microbiota and gut maturation. Crit Rev Food Sci Nutr. https ://doi.
org/10.1080/10408 398.2017.14140 30
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment 
search tool. J Mol Biol 215(3):403–410
Arboleya S, Watkins C, Stanton C, Ross RP (2016) Gut bifidobacteria popula-
tions in human health and aging. Front Microbiol 7:1204
Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, 
Kumagai H, Ashida H, Hirose J, Kitaoka M (2011) Physiology of consump-
tion of human milk oligosaccharides by infant gut-associated bifidobac-
teria. J Biol Chem 286(40):34583–34592
Bottacini F, O’Connell Motherway M, Kuczynski J, O’Connell KJ, Serafini F, 
Duranti S, Milani C, Turroni F, Lugli GA, Zomer A, Zhurina D, Riedel C, 
Ventura M, van Sinderen D (2014) Comparative genomics of the Bifido-
bacterium breve taxon. BMC Genomics 15:170
de Ruyter PG, Kuipers OP, de Vos WM (1996) Controlled gene expression 
systems for Lactococcus lactis with the food-grade inducer nisin. Appl 
Environ Microbiol 62(10):3662–3667
Egan M, Motherway MO, Kilcoyne M, Kane M, Joshi L, Ventura M, van Sinderen 
D (2014) Cross-feeding by Bifidobacterium breve UCC2003 during 
co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based 
medium. BMC Microbiol 14:282
Fuhrer A, Sprenger N, Kurakevich E, Borsig L, Chassard C, Hennet T (2010) Milk 
sialyllactose influences colitis in mice through selective intestinal bacte-
rial colonization. J Exp Med 207(13):2843–2854
Garrido D, Dallas DC, Mills DA (2013) Consumption of human milk glycoconju-
gates by infant-associated bifidobacteria: mechanisms and implications. 
Microbiology 159(Pt 4):649–664
Garrido D, Ruiz-Moyano S, Kirmiz N, Davis JC, Totten SM, Lemay DG, Ugalde JA, 
German JB, Lebrilla CB, Mills DA (2016) A novel gene cluster allows pref-
erential utilization of fucosylated milk oligosaccharides in Bifidobacterium 
longum subsp. longum SC596. Sci Rep 6:35045
Goulas TK, Goulas AK, Tzortzis G, Gibson GR (2007) Molecular cloning and 
comparative analysis of four beta-galactosidase genes from Bifidobacte-
rium bifidum NCIMB41171. Appl Microbiol Biotechnol 76(6):1365–1372
James K, Motherway MO, Bottacini F, van Sinderen D (2016) Bifidobacterium 
breve UCC2003 metabolises the human milk oligosaccharides lacto-
N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct 
pathways. Sci Rep 6:38560
Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism 
shapes the human gut microbiota. Nat Rev Microbiol 10(5):323–335
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 227(5259):680–685
Lewis ZT, Mills DA (2017) Differential Establishment of bifidobacteria in the 
breastfed infant gut. Nestle Nutr Inst Workshop Ser 88:149–159
LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills 
DA, German JB (2007) Glycoprofiling of bifidobacterial consumption of 
human milk oligosaccharides demonstrates strain specific, preferential 
consumption of small chain glycans secreted in early human lactation. J 
Agric Food Chem 55(22):8914–8919
Macfarlane GT, Steed H, Macfarlane S (2008) Bacterial metabolism and health-
related effects of galacto-oligosaccharides and other prebiotics. J Appl 
Microbiol 104(2):305–344
Maldonado-Gomez MX, Martinez I, Bottacini F, O’Callaghan A, Ventura M, van 
Sinderen D, Hillmann B, Vangay P, Knights D, Hutkins RW, Walter J (2016) 
Stable engraftment of Bifidobacterium longum AH1206 in the human gut 
depends on individualized features of the resident microbiome. Cell Host 
Microbe 20(4):515–526
Milani C, Lugli GA, Duranti S, Turroni F, Mancabelli L, Ferrario C, Mangifesta M, 
Hevia A, Viappiani A, Scholz M, Arioli S, Sanchez B, Lane J, Ward DV, Hickey 
R, Mora D, Segata N, Margolles A, van Sinderen D, Ventura M (2015) 
Bifidobacteria exhibit social behavior through carbohydrate resource 
sharing in the gut. Sci Rep 5:15782
Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, Belzer C, Delgado 
Palacio S, Arboleya Montes S, Mancabelli L, Lugli GA, Rodriguez JM, 
Bode L, de Vos W, Gueimonde M, Margolles A, van Sinderen D, Ventura 
M (2017) The first microbial colonizers of the human gut: composition, 
activities, and health implications of the infant gut microbiota. Microbiol 
Mol Biol Rev. https ://doi.org/10.1128/MMBR.00036 -17
Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, Ashida H, Yamamoto 
K (2010) Cooperation of beta-galactosidase and beta-N-acetylhexosami-
nidase from bifidobacteria in assimilation of human milk oligosaccharides 
with type 2 structure. Glycobiology 20(11):1402–1409
Moller PL, Jorgensen F, Hansen OC, Madsen SM, Stougaard P (2001) Intra- and 
extracellular beta-galactosidases from Bifidobacterium bifidum and B. 
infantis: molecular cloning, heterologous expression, and comparative 
characterization. Appl Environ Microbiol 67(5):2276–2283
O’Connell KJ, O’Connell Motherway M, O’Callaghan J, Fitzgerald GF, Ross RP, 
Ventura M, Stanton C, van Sinderen D (2013) Metabolism of four alpha-
glycosidic linkage-containing oligosaccharides by Bifidobacterium breve 
UCC2003. Appl Environ Microbiol 79(20):6280–6292
O’Connell Motherway M, Fitzgerald GF, van Sinderen D (2011) Metabolism of 
a plant derived galactose-containing polysaccharide by Bifidobacterium 
breve UCC2003. Microb Biotechnol 4(3):403–416
O’Connell Motherway M, Kinsella M, Fitzgerald GF, van Sinderen D (2013) Tran-
scriptional and functional characterization of genetic elements involved 
in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. 
Microb Biotechnol 6(1):67–79
O’Riordan K, Fitzgerald GF (1998) Evaluation of bifidobacteria for the produc-
tion of antimicrobial compounds and assessment of performance in cot-
tage cheese at refrigeration temperature. J Appl Microbiol 85(1):103–114
Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L (2016) Bifidobacteria and 
butyrate-producing colon bacteria: importance and strategies for their 
stimulation in the human gut. Front Microbiol 7:979
Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL (2010) Examination 
of faecal Bifidobacterium populations in breast- and formula-fed infants 
during the first 18 months of life. Microbiology 156(Pt 11):3329–3341
Ruiz L, Motherway MO, Lanigan N, van Sinderen D (2013) Transposon 
mutagenesis in Bifidobacterium breve: construction and characterization 
of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003. 
PLoS ONE 8(5):e64699
Sela DA (2011) Bifidobacterial utilization of human milk oligosaccharides. Int J 
Food Microbiol 149(1):58–64
Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL (2014) Breast milk 
oligosaccharides: structure-function relationships in the neonate. Annu 
Rev Nutr 34:143–169
Tailford LE, Crost EH, Kavanaugh D, Juge N (2015) Mucin glycan foraging in the 
human gut microbiome. Front Genet 6:81
Terzaghi BE, Sandine WE (1975) Improved medium for lactic streptococci and 
their bacteriophages. Appl Microbiol 29(6):807–813
Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sanchez B, Bidossi A, 
Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni 
M, Fitzgerald GF, Mills D, Margolles A, Kelly D, van Sinderen D, Ventura 
M (2010) Genome analysis of Bifidobacterium bifidum PRL2010 reveals 
metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci 
USA 107(45):19514–19519
Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr C, 
Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A, De Bellis G, 
O’Toole PW, van Sinderen D, Marchesi JR, Ventura M (2012) Diversity of 
bifidobacteria within the infant gut microbiota. PLoS ONE 7(5):e36957
Turroni F, Milani C, Duranti S, Ferrario C, Lugli GA, Mancabelli L, van Sinderen 
D, Ventura M (2018a) Bifidobacteria and the infant gut: an example of co-
evolution and natural selection. Cell Mol Life Sci 75(1):103–118
Turroni F, Milani C, Duranti S, Mahony J, van Sinderen D, Ventura M (2018b) 
Glycan utilization and cross-feeding activities by bifidobacteria. Trends 
Microbiol 26(4):339–350
Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT (2012) The 
predominance of type I oligosaccharides is a feature specific to human 
breast milk. Adv Nutr 3(3):473S–482S
van den Broek LA, Hinz SW, Beldman G, Vincken JP, Voragen AG (2008) 
Bifidobacterium carbohydrases-their role in breakdown and synthesis of 
(potential) prebiotics. Mol Nutr Food Res 52(1):146–163
Page 15 of 15Ambrogi et al. AMB Expr             (2019) 9:9 
Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB (2007) In vitro 
fermentability of human milk oligosaccharides by several strains of 
bifidobacteria. Mol Nutr Food Res 51(11):1398–1405
Wells JM, Wilson PW, Le Page RW (1993) Improved cloning vectors and trans-
formation procedure for Lactococcus lactis. J Appl Bacteriol 74(6):629–636
Yoshida E, Sakurama H, Kiyohara M, Nakajima M, Kitaoka M, Ashida H, Hirose 
J, Katayama T, Yamamoto K, Kumagai H (2012) Bifidobacterium longum 
subsp. infantis uses two different beta-galactosidases for selectively 
degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 
22(3):361–368
